GKOS | Glaukos CorporationNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$233.04
-$5.57 (-2.33%)

Glaukos Corporation (GKOS) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Dec 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $233.04 vs 50 $175.31 / 200 $142.64
Projection
No cross projected
Test
No active test
Last cross
Golden cross 19 Dec 2025 ยท projected 20 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $237.60 vs 50 $136.71 / 200 $104.15
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 4 Sep 2023 ยท projected 19 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $233.04 vs 50 $180.54 / 200 $166.72
Projection
No cross projected
Test
No active test
Last cross
Golden cross 22 Apr 2026 ยท projected 22 bars out

Cross history

25
crosses on record since 2017
13 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
22 Apr 2026Golden4-hour22 bars outNot tested
30 Mar 2026Death4-hour28 bars out4 bar cross test
19 Dec 2025Golden steepdaily20 bars outNot tested
28 Nov 2025Golden4-hour26 bars outNot tested
11 Aug 2025Death4-hour13 bars outโ€”

About GKOS

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$134M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.